Holen Sie sich die Stockscreener-App
23.32
2.37%
0.5263
Schlusskurs vom Vortag:
$22.79
Offen:
$22.92
24-Stunden-Volumen:
20,826
Relative Volume:
0.04
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.56%
1M Leistung:
-7.75%
6M Leistung:
+117.83%
1J Leistung:
+3.97%
1-Tages-Spanne:
$22.92
$23.56
1-Wochen-Bereich:
$21.63
$25.83
52-Wochen-Spanne:
$9.60
$28.44
Defiance Daily Target 2 X Long Lly Etf Stock (LLYX) Company Profile
Firmenname
Defiance Daily Target 2 X Long Lly Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare LLYX vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LLYX
Defiance Daily Target 2 X Long Lly Etf
|
23.48 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.16 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.11 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
273.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.17 | 124.43B | 0 | 0 | 0 | 0.00 |
Defiance Daily Target 2 X Long Lly Etf Aktie (LLYX) Neueste Nachrichten
Defiance ETFs Surpass $8 Billion in Assets Under Management - Chartmill
Defiance ETFs Announces Closure of Select Funds - The Manila Times
Defiance Daily Target 2X Long LLY ETF (NYSE:LLYX) Stock Quote - The Chronicle-Journal
Defiance Launches RKTL: The First Daily 2X Long ETF for Rocket Companies, Inc. - Yahoo Finance
The 2X Long INTC (INTW) fund rose by 13.10% with a trading value of $111.98 million. - Sahm
Defiance Daily Target 2X Short LLY ETF (LLYZ) AI-Powered Stock Analysis - Meyka
Eli Lilly and Co’s significant oral weight-loss drug trial achieves new progress: Switching from injection to oral form effectively maintains weight loss results, with an application for market approval submitted to the FDA. - 富途牛牛
Market Chatter: Eli Lilly and Company to Reduce Prices of Its Diabetes, Weight-Loss Drugs in Canada by 20% or More - 富途牛牛
Market Chatter: Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026 - 富途牛牛
Best Stocks Under $50 Right Now - Benzinga
LLYZDefiance Daily Target 2X Short LLY ETF Earnings - Finviz
Fat Pitch FinancialsDefiance Launches IRE: The First 2X Long ETF for IREN Limited - FinancialContent
Defiance Daily Target 2X Long LMND ETF Holdings List (NASDAQ:LMNX) - MarketBeat
MSTX: Good Way To Boost Gains On Strategy, But Beware Of The Risks (NASDAQ:MSTX) - Seeking Alpha
Defiance Daily Target 2X Short LLY ETF (LLYZ) options chain - Yahoo
Defiance Daily Target 2X Short LLY ETF (LLYZ) latest stock news and headlines - Yahoo
Check out Defiance Daily Target 2X Short LLY ETF's stock price (LLYZ) in real time - CNBC
Leveraged ETFs: Single-Stock Surge - Seeking Alpha
Single-Stock Surge in Leveraged ETFs - ETF Database
Defiance Has A New ETF For High-Stakes Pharma Traders - Sahm
Defiance ETFs launches 2X short ETF on Eli Lilly - MSN
Tidal Trust IIDefiance Daily Target 2X Short LLY ETF - CMLviz
Largest borrow rate increases among liquid names - TipRanks
US launches from 28th August to 4th September, 2025 - ETF Express
Defiance Launches 2X Short ETF on Eli Lilly for Retail Investors - AInvest
Defiance’s LLYZ ETF: A Leveraged Bet Against Eli Lilly Amid Biopharma Sector Turbulence - AInvest
Attachment - GlobeNewswire
Defiance Launches LLYZ: The First 2X Short ETF for Eli Lilly - GlobeNewswire
Defiance Launches LLYZ: A New 2X Short ETF for Eli Lilly Investors - AInvest
Weekly ETF Industry News Recap | August 25August 29, 2025 - Trackinsight
Largest Borrow Rate Increases Among Liquid Stocks - AInvest
U.S. Stock ETF Tracking | Eli Lilly and Co's weight loss drug is expected to submit for FDA approval within the year, resulting in a more than 11% increase in the 2x long LLY ETF; international oil prices have fallen to nearly $60 per barrel, leading to o - 富途牛牛
Novo Nordisk Plunges 2.6% Amid Legal Storm and Rival Drug Data – What’s Next for NVO? - AInvest
Eli Lilly's LLY Surges 4.38% on Groundbreaking Obesity Drug Data – What's Next for the Pharma Giant? - AInvest
Best-Performing Leveraged ETFs of Last Week - Yahoo Finance
Big Tech Woes Power Surge in Inverse Single-Stock ETFs - Yahoo Finance
Novo Nordisk Surges 2.46% Amid Leadership Shift and Sector Volatility – What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3.36% Amid UK Price Hike and AI-Driven Obesity Deal: What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3% on Insider Buying and Regulatory Drama – What’s Next? - AInvest
Eli Lilly Soars on Insider Buying Amid Regulatory Storm: A 3% Rally Amid Legal and Trial Turmoil - AInvest
Eli Lilly Surges 2.48% Amid Regulatory Turmoil and Sector Volatility – What’s Fueling the Rally? - AInvest
Novo Nordisk Surges 4.7% Amid Obesity Drug Rivalry: Is This the New Benchmark? - AInvest
US ETF Tracker | Trump announces nomination of Stephen Moore for Federal Reserve governor, double-leveraged small gold miners index ETF rises nearly 3%, Eli Lilly and Co's new drug underperforms expectations, double-leveraged LLY ETF falls over 28 - 富途牛牛
U.S. Market Outlook | Equity Index Futures Rise, Super Micro Computer (SMCI.US) Falls Post-Earnings, Trump to Make Statement After Market Close - 富途牛牛
Novo Nordisk Plunges 3.45%: Is This the Bottom or a Deeper Downtrend? - AInvest
Novo Nordisk Plunges 4.56%—Is This a Golden Entry Point or a Deepening Abyss? - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Novo Nordisk Skyrockets 4.78%—What’s Fueling This High-Stakes Surge? - AInvest
Novo Nordisk Skyrockets 2.71% Intraday—Is This the Dawn of a New Obesity Drug Era? - AInvest
U.S. ETF Tracking | Online Car-hailing giant Uber Technologies will invest $300 million in electric car manufacturer Lucid, leading to a 73% surge in the 2x leveraged LCID ETF; the 2x leveraged QBTS ETF rose by over 27%. - 富途牛牛
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 2-6, 2025 - Trackinsight
Finanzdaten der Defiance Daily Target 2 X Long Lly Etf-Aktie (LLYX)
Es liegen keine Finanzdaten für Defiance Daily Target 2 X Long Lly Etf (LLYX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):